Evidence map›Paper›PMID 29317836›Full record

ArticleOncoTargets and therapy2018

Prognosis of patients with primary malignant main stem bronchial tumors: 7,418 cases based on the SEER database.

Ke Ma, Fenghao Sun, Xiaodong Yang, Shuai Wang, Lin Wang, Yulin Jin, Yu Shi, Wei Jiang, Cheng Zhan, Qun Wang

Abstract read
In one paragraph

Article in OncoTargets and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ke Ma *Department of Thoracic Surgery, Zhongshan Hospital of Fudan University, Shanghai, People's Republic of China.
Fenghao Sun *Department of Thoracic Surgery, Zhongshan Hospital of Fudan University, Shanghai, People's Republic of China.
Xiaodong YangDepartment of Thoracic Surgery, Zhongshan Hospital of Fudan University, Shanghai, People's Republic of China.
Shuai WangDepartment of Thoracic Surgery, Zhongshan Hospital of Fudan University, Shanghai, People's Republic of China.
Lin WangDepartment of Thoracic Surgery, Zhongshan Hospital of Fudan University, Shanghai, People's Republic of China.
Yulin JinDepartment of Thoracic Surgery, Zhongshan Hospital of Fudan University, Shanghai, People's Republic of China.
Yu ShiDepartment of Thoracic Surgery, Zhongshan Hospital of Fudan University, Shanghai, People's Republic of China.
Wei JiangDepartment of Thoracic Surgery, Zhongshan Hospital of Fudan University, Shanghai, People's Republic of China.
Cheng ZhanDepartment of Thoracic Surgery, Zhongshan Hospital of Fudan University, Shanghai, People's Republic of China.
Qun WangDepartment of Thoracic Surgery, Zhongshan Hospital of Fudan University, Shanghai, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to identify risk factors for patients with malignant main stem bronchial tumors (MBTs) and to develop a nomogram for predicting prognosis in those patients using data from the Surveillance, Epidemiology, and End Results (SEER) database.

methodA process was used for case screening from the SEER database. The effect of prognostic factors on survival was evaluated using the Kaplan-Meier method and log-rank test, a competing risk model, and the Cox proportional hazards regression model. A nomogram was established for predicting 1-, 3-, and 5-year overall survival (OS) in patients with MBTs.

resultsA total of 7,418 cases were included in this study. Age, gender, pathologic grade, histologic type, tumor size, involvement of lymph nodes, tumor extension, chemotherapy, and surgery were identified as independent risk factors by univariate and multivariate analyses. A nomogram was established based on the results of the Cox model, which was validated by a C-index of 0.672 (95% CI, 0.664-0.680), and a group of calibration plots.

conclusionAge, gender, pathologic grade, histologic type, tumor size, involvement of lymph nodes, tumor extension, chemotherapy, and surgery were independent risk factors for OS of patients with MBTs. A nomogram was formulated to predict 1-, 3-, and 5-year OS in patients with MBTs based on individual clinical characteristics.

Indexed as

malignant main stem bronchial tumornomogramprognosisrisk factors

Identifiers

PMID29317836
PMCPMC5744741

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.